May 2, 2018 / 11:36 AM / 3 months ago

BRIEF-Avadel Pharmaceuticals Reports Q1 Adjusted Loss Per Share $0.34

May 2 (Reuters) - Avadel Pharmaceuticals PLC:

* AVADEL PHARMACEUTICALS REPORTS FIRST QUARTER 2018 RESULTS

* Q1 GAAP LOSS PER SHARE $0.32

* Q1 REVENUE $33.3 MILLION VERSUS I/B/E/S VIEW $29.5 MILLION

* Q1 EARNINGS PER SHARE VIEW $-0.27 — THOMSON REUTERS I/B/E/S

* SEES FY 2018 REVENUE $105 MILLION TO $125 MILLION

* AVADEL PHARMACEUTICALS - CASH AND MARKETABLE SECURITIES AT MARCH 31, 2018 WERE $198.2 MILLION, UP FROM $94.1 MILLION AT DECEMBER 31, 2017

* AVADEL PHARMACEUTICALS - REITERATING FY 2018 GUIDANCE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below